DKwiatkowski
TL3 Regular · Linköping, SE
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 6 October 2024 · last posted 4d · groups: newcomer-guides
139 posts, newest first. Showing up to 150.
-
Why the Start Here categories exist, and what they are not for Replied, post #31 · Start Here › Welcome · 24 Jul 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
A calculator that gives a right answer to the wrong question Replied, post #36 · Data & Tools › Calculators · 23 Jul 2026 · 22 likes Maintaining a calculator means checking the arithmetic against hand-worked cases at each review, not checking that it still loads.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #27 · Clinical › Bloodwork · 22 Jul 2026 · 27 likes Answering the question post #23 raises rather than the one it answers. The claim about egfr fluctuation upthread is stronger than its source supports. I have read the…
-
Tracking intake honestly when appetite is absent Replied, post #108 · Nutrition & Training › Protein & intake · 21 Jul 2026 · 0 likes Having read the whole tracking intake thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
-
Retatrutide mass and identity: what a report should show Replied, post #22 · Compounds › Retatrutide · 20 Jul 2026 · 1 like Answering the question post #21 raises rather than the one it answers. Reading back through the retatrutide mass and identity threads from last year, the same three…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #44 · Practice › Interactions · 19 Jul 2026 · 27 likes Delayed gastric emptying and oral is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Forced degradation studies: designing one that is informative Replied, post #98 · Analytics › Method validation · 14 Jul 2026 · 15 likes Adding the measurement that post #97 says would settle it. The most useful single question about a method: what would it fail to detect? Every method has an answer and…
-
Which categories are strict and which are relaxed, honestly Replied, post #13 · Start Here › Welcome · 14 Jul 2026 · 19 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #20 · Practice › Dosing & titration · 10 Jul 2026 · 0 likes Four-week escalation interval has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here…
-
Follow-up: Sleep quality changes during weight loss Replied, post #64 · Wellbeing › Sleep · 8 Jul 2026 · 2 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #21 · Start Here › Welcome · 8 Jul 2026 · 15 likes The documentation on Reading order is better than this thread and I say that as someone who has posted in the thread.
-
Revisiting: What pooling buys you and what it destroys Replied, post #77 · Evidence › Meta-analyses · 3 Jul 2026 · 3 likes Pooling buys has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Electrolyte supplements: which ones do anything Replied, post #45 · Nutrition & Training › Hydration & electrolytes · 2 Jul 2026 · 23 likes Adding the measurement that post #42 says would settle it. Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #9 · Practice › Side effects · 23 Jun 2026 · 15 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #54 · Analytics › HPLC & UHPLC · 20 Jun 2026 · 0 likes Purity by chromatography answers "what proportion of what I detected is the intended species". It does not answer how much is in the vial, which is a separate assay.
-
Why this subcategory is stricter about sourcing than most Replied, post #44 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 28 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #79 · Practice › Administration · 15 Jun 2026 · 7 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
[2026 update] What a good consultation looks like from the other side Replied, post #37 · Clinical › Prescriber conversations · 14 Jun 2026 · 16 likes Picking up post #35: that is the part I would want checked first. I would keep good consultation and the decision it usually gets used for separate in this thread. They…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #50 · Outcomes › Progress reports · 14 Jun 2026 · 21 likes Thank you for taking the time. That was more work than a reply usually is.
-
Revisiting: The best-written scientific paper you have read Replied, post #20 · Lounge › Off topic · 7 Jun 2026 · 0 likes The arithmetic on best-written scientific paper is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #39 · Analytics › Impurities & related substances · 7 Jun 2026 · 0 likes Worth stating the null on Endotoxin before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
[2026 update] Waist circumference technique and its repeatability Replied, post #14 · Outcomes › Progress reports · 3 Jun 2026 · 33 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #35 · Practice › Storage & stability · 31 May 2026 · 7 likes This follows post #32 rather than contradicting it. Practical note on Mean kinetic temperature: write down what you expect before you look. The number of times I have…
-
GLP-1 receptor distribution: central and peripheral Replied, post #60 · Pharmacology › Receptor biology · 31 May 2026 · 20 likes Agreed on GLP-1 receptor distribution, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #18 · Access › Insurance & coverage · 26 May 2026 · 28 likes Appeal is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Naming conventions for research peptides and the confusion they cause Replied, post #6 · Compounds › Other compounds · 22 May 2026 · 13 likes No disagreement from me. Posting only so the question does not look ignored.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #9 · Documentation › Doc review · 19 May 2026 · 13 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. The limitations section is the part most often thin at review and…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #56 · Compounds › Repair & healing peptides · 18 May 2026 · 1 like Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #11 · Start Here › How to Ask · 17 May 2026 · 8 likes Taking post #8 at face value and following it one step further. If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #50 · Compounds › Tirzepatide · 14 May 2026 · 26 likes What I would tell a new member reading about Tirzepatide and nausea for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #41 · Practice › Interactions · 10 May 2026 · 0 likes Answering the question post #39 raises rather than the one it answers. Widely repeated interaction claim is a good example of a question where the honest answer is…
-
Personal import allowances, compared — a second dataset Replied, post #119 · Access › International · 8 May 2026 · 12 likes The number people quote for Personal import allowances is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #37 · Analytics › Impurities & related substances · 8 May 2026 · 0 likes Confirming post #34 from a second method, which matters more than confirming it from a second person. Filing a mild objection to the consensus on Residual solvents and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #115 · Compounds › Tirzepatide · 8 May 2026 · 1 like SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #98 · Devices › Syringes & needles · 8 May 2026 · 9 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
-
Official shortage notices and what they authorise Replied, post #32 · Access › Shortages · 3 May 2026 · 21 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #22 · Safety › Contraindications · 28 Apr 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #56 · Practice › Administration · 24 Apr 2026 · 0 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. Leaving the needle in for a couple of seconds after depressing the plunger reduces…
-
Adolescents: a distinct evidence base — one year on Replied, post #85 · Clinical › Special populations · 11 Apr 2026 · 29 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much. That holds for the case as described. Change…
-
Spike-and-recover accuracy for a peptide assay Replied, post #114 · Analytics › Method validation · 10 Apr 2026 · 31 likes On post #110 — agreed on the reasoning, with one qualification. The most useful single question about a method: what would it fail to detect? Every method has an answer…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #97 · Pharmacology › Pharmacokinetics · 4 Mar 2026 · 4 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #88 · Meta › Site feedback · 3 Mar 2026 · 8 likes Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider.
-
Why retatrutide discussion here is more cautious than elsewhere Started this topic · Compounds › Retatrutide · 2 Mar 2026 · 19 likes Why retatrutide discussion here is more cautious than elsewhere I have a specific reason for asking rather than idle curiosity, and the context is below. A question…
-
Revisiting: Absolute versus relative contraindications Replied, post #35 · Safety › Contraindications · 2 Mar 2026 · 0 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. I have changed my mind on this once…
-
The lowest dose that does anything: is that a real question? Replied, post #2 · Practice › Dosing & titration · 28 Feb 2026 · 0 likes Lowest dose sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Measurement error in a self-reported exposure Replied, post #111 · Evidence › Study critique · 27 Feb 2026 · 0 likes Post #108 is right about the mechanism and I think understates the practical bit. Hold a trial to the standard something could actually have met. A criticism that no…
-
Five questions in one post gets you one answer — how to split them Replied, post #17 · Start Here › How to Ask · 21 Feb 2026 · 13 likes No disagreement from me. Posting only so the question does not look ignored.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #48 · Pharmacology › Pharmacokinetics · 20 Feb 2026 · 3 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #50 · Practice › Dosing & titration · 17 Feb 2026 · 22 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
-
Realistic expectations for strength while losing weight quickly Replied, post #62 · Nutrition & Training › Resistance training · 13 Feb 2026 · 29 likes Coming back to post #60, because the follow-up matters more than the original answer. Cardiovascular work has its own benefits and is not a substitute for a resistance…
-
[2026 update] What a purity-only report leaves out Replied, post #9 · Sourcing › Independent verification · 26 Jan 2026 · 28 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #13 · Compounds › Secretagogues & GH axis · 20 Jan 2026 · 0 likes For anyone finding this later: the short answer on Evidence quality is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Tracking that stops updating and then resumes — the long version Replied, post #68 · Sourcing › Logistics · 19 Jan 2026 · 21 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #51 · Documentation › Doc review · 19 Jan 2026 · 0 likes The limitations section is the part most often thin at review and most often load-bearing afterwards. That holds under the stated conditions and I have stated them.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #16 · Practice › Storage & stability · 5 Jan 2026 · 0 likes The two questions that get merged here are whether material is degraded and whether it is contaminated. Storage affects both and they need different answers and…
-
Early satiety becoming a problem rather than a benefit Replied, post #22 · Practice › Side effects · 4 Jan 2026 · 18 likes On early satiety I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
-
Coverage in the US: a map of the usual obstacles Replied, post #31 · Regional › North America · 3 Jan 2026 · 19 likes Reading back through the coverage threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
-
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #4 · Sourcing › Payments · 14 Dec 2025 · 11 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #23 · Compounds › Retatrutide · 14 Dec 2025 · 2 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #32 · Compounds › Tirzepatide · 4 Dec 2025 · 0 likes The arithmetic in post #29 is right; the assumption feeding it is the part to check. Nausea profile: some people report tirzepatide as less nausea-prone than…
-
Documentation that appears only after payment Replied, post #87 · Sourcing › Red flags · 25 Nov 2025 · 25 likes Documentation has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Temperature loggers worth the money — the long version Replied, post #79 · Devices › Cold chain · 22 Nov 2025 · 0 likes Arrival condition tells you about the last few hours and very little about the middle of the journey. A pack that is soft on arrival may have been soft for four days or…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #36 · Compounds › Semaglutide · 20 Nov 2025 · 3 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Pen dose counters: what a click does and does not guarantee Replied, post #54 · Devices › Pens & autoinjectors · 16 Nov 2025 · 15 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
[2026 update] Long-time reader, first-time poster Replied, post #24 · Lounge › Introductions · 10 Nov 2025 · 8 likes Welcome. The short version of the culture: be specific, date everything, and say when you are guessing. That is genuinely the whole of it. Not the answer, but possibly…
-
Prescription requirements and telehealth models Replied, post #4 · Sourcing › Regulatory · 6 Nov 2025 · 9 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. On reflection I would soften that…
-
Sleep quality changes during weight loss — what changed since Replied, post #47 · Wellbeing › Sleep · 1 Nov 2025 · 17 likes A referral for a proper sleep study answers in one night what months of forum discussion cannot.
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #16 · Analytics › Impurities & related substances · 24 Oct 2025 · 27 likes Particulates sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Personal import allowances, compared — a second dataset Replied, post #12 · Access › International · 21 Oct 2025 · 31 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #26 · Compounds › Semaglutide · 13 Oct 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #82 · Practice › Storage & stability · 13 Oct 2025 · 0 likes Adding the measurement that post #79 says would settle it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #6 · Analytics › Method validation · 13 Oct 2025 · 3 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it. That is the…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #13 · Compounds › Tirzepatide · 8 Oct 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
How to tell whether your question is already answered on a maintained page Replied, post #2 · Start Here › Welcome · 2 Oct 2025 · 13 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
-
Cost per delivered dose, which is the number that matters Replied, post #10 · Access › Pricing · 25 Sep 2025 · 1 like A pen and a vial are not the same product. Dead volume, wastage and the number of doses actually obtainable all differ.
-
Tracking that stops updating and then resumes — the long version Replied, post #15 · Sourcing › Logistics · 15 Sep 2025 · 32 likes Post #12 is right about the mechanism and I think understates the practical bit. Document outcomes rather than forecasting them. A forecast in this category reads as…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #121 · Compounds › Tirzepatide · 8 Sep 2025 · 9 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
About the Prescriber conversations category Replied, post #4 · Clinical › Prescriber conversations · 30 Aug 2025 · 20 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Tracking that stops updating and then resumes — the long version Replied, post #8 · Sourcing › Logistics · 24 Aug 2025 · 5 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Are there stupid questions here? A staff answer, at length Replied, post #83 · Start Here › Welcome · 17 Aug 2025 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: Why appetite effects are mostly central Replied, post #9 · Pharmacology › Receptor biology · 1 Aug 2025 · 3 likes Confirming post #6 from a second method, which matters more than confirming it from a second person. Nothing in receptor biology tells you what is in the vial, which is…
-
Pages past their review date, listed Replied, post #11 · Meta › Wiki maintenance · 29 Jul 2025 · 0 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. Whatever the answer on pages past turns out to be, the method for…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #86 · Outcomes › Progress reports · 27 Jul 2025 · 1 like The thing about 18-month record that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #71 · Clinical › Comorbidities · 14 Jul 2025 · 11 likes Worth separating two things that post #67 runs together. Whatever the answer on Cardiovascular risk turns out to be, the method for getting there is the same: state the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #60 · Compounds › Semaglutide · 8 Jul 2025 · 31 likes Coming back to post #56, because the follow-up matters more than the original answer. Solutions of semaglutide can look faintly opalescent without anything being wrong.…
-
Counter-ion content and its effect on measured mass Replied, post #75 · Analytics › Mass spectrometry · 26 Jun 2025 · 11 likes Response in electrospray is not proportional to abundance across different species. Using peak intensities from a mass spectrum to estimate proportions is a mistake…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #57 · Pharmacology › Pharmacokinetics · 21 Jun 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #59 · Compounds › Repair & healing peptides · 18 Jun 2025 · 24 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Reading an MS report that only gives you a single number Replied, post #111 · Analytics › Mass spectrometry · 18 Jun 2025 · 31 likes Taking post #110 at face value and following it one step further. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #47 · Evidence › Trials · 7 Jun 2025 · 3 likes Something worth flagging about Comparators chosen for regulatory reasons: the strongest-sounding claims in this thread are the ones with no source attached, which is…
-
Reverting an edit that had no revision note Replied, post #7 · Meta › Wiki maintenance · 29 May 2025 · 17 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Pre-registering a personal experiment, seriously Replied, post #6 · Research Methods › N-of-1 designs · 25 May 2025 · 17 likes Nobody has said the unglamorous part of pre-registering a personal experiment yet, so: most of the variation is explained by things that are boring to write about and…
-
Sequence verification for an obscure compound: how it is done Replied, post #43 · Compounds › Other compounds · 24 May 2025 · 3 likes Sequence verification sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Which panel is worth repeating and which is worth ignoring Replied, post #22 · Clinical › Bloodwork · 20 May 2025 · 8 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. The step…
-
Lean mass preservation: what the evidence supports Replied, post #19 · Outcomes › Body composition · 16 May 2025 · 28 likes Bone mineral density changes with substantial weight loss are measurable and slow, and are one of the better reasons to have a baseline scan.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #110 · Compounds › Cagrilintide & amylin analogues · 5 May 2025 · 0 likes I read post #108 twice before replying, because I had assumed the opposite. A note on scope: what I am saying about amylin analogue mechanism applies to the case in the…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #4 · Compounds › Repair & healing peptides · 28 Apr 2025 · 0 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
-
Why the timeline is on the right and not the left Replied, post #12 · Meta › Site feedback · 28 Apr 2025 · 0 likes That is a cleaner way of putting what I was circling around.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #112 · Evidence › Journal club · 22 Apr 2025 · 3 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #76 · Practice › Reconstitution · 10 Apr 2025 · 0 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Reading an MS report that only gives you a single number Replied, post #48 · Analytics › Mass spectrometry · 8 Apr 2025 · 0 likes Post #45 describes the usual case. This is about the unusual one. An acylated peptide has a mass that reflects the modification, so comparing against the mass of the…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #67 · Documentation › Doc review · 20 Mar 2025 · 2 likes The limitations section is the part most often thin at review and most often load-bearing afterwards.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #66 · Sourcing › Vendor reports · 17 Mar 2025 · 13 likes Where you submitted more than one vial from a consignment, say so. Intra-consignment comparison is one of the more useful things an individual can contribute. The…
-
Scheduled maintenance and what will be unavailable Replied, post #74 · Meta › Announcements · 15 Mar 2025 · 17 likes On scheduled maintenance the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #112 · Compounds › Other compounds · 11 Mar 2025 · 25 likes I would rather this thread reach "we do not know" about Research-use-only status than reach a confident answer that nobody can support when asked.
-
Transit times by route, from a logged dataset — the long version Replied, post #69 · Sourcing › Logistics · 11 Mar 2025 · 1 like Adding thanks rather than a view. I do not have a view worth the space.
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #29 · Analytics › Mass spectrometry · 8 Mar 2025 · 4 likes Reporting rather than recommending, on adducts. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #31 · Sourcing › Regulatory · 28 Feb 2025 · 0 likes Where the pharmaceutical compounding rules reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #104 · Data & Tools › Calculators · 25 Feb 2025 · 4 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
-
Distinguishing a deletion sequence by mass alone Replied, post #101 · Analytics › Mass spectrometry · 18 Feb 2025 · 0 likes Post #100 is the version of this I will quote in future. One addition. Resolution and mass accuracy are different specifications. An instrument can resolve two species…
-
Scheduled maintenance and what will be unavailable Replied, post #45 · Meta › Announcements · 16 Feb 2025 · 22 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #34 · Evidence › Meta-analyses · 15 Feb 2025 · 6 likes I had written a reply contradicting post #30 and deleted it. Here is what survived. A network meta-analysis rests on a transitivity assumption that is rarely tested and…
-
Journal club: STEP 4 and what a withdrawal design can prove Started this topic · Evidence › Journal club · 14 Feb 2025 · 11 likes On the subject in the title: Journal club: STEP 4 and what a withdrawal design can prove Working notes rather than a conclusion. Session topic: STEP 4 ( JAMA , 2021).…
-
Follow-up: What other technical communities get right that we do not Replied, post #15 · Lounge › Off topic · 11 Feb 2025 · 7 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. I would be glad to be shown a cleaner…
-
What we do not know about retatrutide, listed explicitly Replied, post #91 · Compounds › Retatrutide · 11 Feb 2025 · 8 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #77 · Data & Tools › Calculators · 4 Feb 2025 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Preparing for an appointment: one page, three questions Replied, post #6 · Clinical › Prescriber conversations · 30 Jan 2025 · 2 likes Good question, well framed, and I would like to see it answered properly.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #11 · Access › International · 24 Jan 2025 · 13 likes Since Cross-border purchase within keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
-
Checking someone else's arithmetic: a worked example thread Replied, post #16 · Practice › Reconstitution · 22 Jan 2025 · 9 likes Post #12 describes the usual case. This is about the unusual one. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Recovery when intake is low: what to cut first Replied, post #43 · Nutrition & Training › Resistance training · 12 Jan 2025 · 5 likes That reframing is the whole thing. The facts I already had.
-
A promotion I argued against, and why I lost Replied, post #57 · Documentation › Doc review · 10 Jan 2025 · 8 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. I am describing what is, rather than…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #11 · Data & Tools › Calculators · 10 Jan 2025 · 1 like Where I part company with post #10, and it is a narrow parting. Precision and significant figures: the calculators do not round to match your input precision. If you…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #46 · Data & Tools › Calculators · 9 Jan 2025 · 8 likes The arithmetic in post #45 is right; the assumption feeding it is the part to check. The most common input error is entering the vial mass in the concentration field.…
-
Oxidation pathways for methionine and tryptophan Replied, post #38 · Analytics › Impurities & related substances · 29 Dec 2024 · 21 likes My understanding of oxidation pathways for methionine is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
-
Washout with a one-week half-life: the arithmetic Replied, post #57 · Research Methods › N-of-1 designs · 3 Dec 2024 · 10 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record.
-
A page that has drifted out of date and needs a maintainer Replied, post #34 · Documentation › Wiki requests · 30 Nov 2024 · 0 likes This follows post #33 rather than contradicting it. The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems…
-
Identical chromatograms across two different lots Replied, post #52 · Sourcing › Red flags · 21 Nov 2024 · 0 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. The most useful contribution to this subcategory is a resolved case written up with…
-
Reading a supplementary appendix and finding the interesting part Replied, post #20 · Evidence › Trials · 9 Nov 2024 · 6 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Time to steady state after a dose increase Replied, post #26 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 30 likes Post #22 and I disagree about the size of the effect, not about the direction. Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption.…
-
Signs of dehydration worth acting on Replied, post #29 · Safety › Adverse events · 13 Oct 2024 · 9 likes The published trial rates come from supervised populations on defined schedules and are not comparable to rates derived from who chooses to post. I would put the burden…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #69 · Access › Shortages · 11 Oct 2024 · 24 likes Post #65 put the caveat in the right place and I want to underline it. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #23 · Clinical › Comorbidities · 6 Oct 2024 · 27 likes Nothing to add, except that this is the answer I would give if asked.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #24 · Compounds › Oral incretins · 25 Sep 2024 · 0 likes Post #20 put the caveat in the right place and I want to underline it. Taking the oral product with more water than instructed reduces absorption rather than helping…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #8 · Analytics › Home & field testing · 23 Sep 2024 · 5 likes Where I part company with post #4, and it is a narrow parting. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #2 · Analytics › Impurities & related substances · 22 Aug 2024 · 7 likes Worth separating two things that the opening post runs together. An impurity profile that changes between lots is more informative than the total. A stable profile…
-
Revisiting: US compounding rules and how they changed Replied, post #3 · Regional › North America · 11 Aug 2024 · 2 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #17 · Evidence › Preprints · 17 Jul 2024 · 2 likes The most useful convention this subcategory has: state the status, state the version, state the date you checked. Three short clauses and the citation stays honest.
-
The mass-error checker and its intended scope Replied, post #125 · Data & Tools › Calculators · 15 Jul 2024 · 5 likes Where the mass-error checker discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
How this community labels and discusses unrefereed work Replied, post #2 · Evidence › Preprints · 3 Jun 2024 · 32 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad.